AVH - AVITA Medical, Inc

[bux2000]

AVH Avita Therapeutics FPO (AVH-ASX)
Last: $0.450

0* 0%
Sector: Pharmaceuticals, Biotechnology & Life Sciences
Add to watchlist
VWAP: $0.439

see moreAvita Medical Ltd (AVH) is a global regenerative medicine company that provides a novel approach to skin regeneration. The products provide treatment solutions which are derived from the regenerative properties of a patient's own skin. A...
Detail

• Charts

• Depth

• Profile

• Overview

• Morningstar
  recommendation

• Morningstar
  research

Depth
as at 19:00:00, Tuesday 23 June, 2020 (AEST)

• Last Change Buy Sell Open High Low VWAP Volume Turnover

$0.450

0* 0% - - $0.450 $0.450 $0.420 $0.439 45,941,883 $20,155,604

• Market depth data is unavailable. Please try again.

I hold a few AVH
It would appear a small amount of AVH has been bought and sold over the past few days at 45c - 42c. I have not been in a position to watch the open on any of these days.
I have quickly tried to sift thought the noise on Hot Copper but am no further ahead always hard to distinguish true knowledge and those hanging to wishful hope.
Although the brokers page has not copied and pasted as I would have wished .....Morningstar has a valuation at 95c but with a SELL recommendation and showing market depth as unavailable.
Even more confused when I find AVHDA closing today at $7.73 ish...........maybe I am the one now hanging to wishful hope
I would like to better understand the situation ...I guess it is to do with what Peter explained previously.

Thanks for your time

bux

 

[peter2]

AVH have redomiciled the company to the US-Nasdaq exchange. AVH shares on the ASX are being converted to AVH-CDI. A CDI ( Chess Depository Interest) is an ASX security that is traded on an overseas exchange (eg US). During this conversion the ASX is using the code AVHDA. The conversion involves a consolidation of shares and a currency adjustment. The conversion is 5:1.

On the ASX, AVH are not trading, instead the AVH-CDIs are trading as AVHDA until all the paperwork is completed. You've already noticed that the price of the AVH-CDIs (AVHDA) is very different. In the last few days they've gone from 9.50 to 7.81.

The price of AVD-CDIs will now follow the price of the US shares that are trading as RCEL.

 

[bux2000]

Hi Peter,

Thank you for taking the time to explain the situation so fully.
I will watch with interest the process unfolding......and just when I thought I was coming to grips with some of the Market processors.
I have always found participation a great teacher......and the help of a friend.

Thank you again for your time

bux

 

[Miner]

AVH published this story today on ASX. The company was pleased but the market slammed a price down by 10%. Yes, it has been sliding on the last three days also
Does anyone suggest what could have been the drive for the negative reaction?
https://www.asx.com.au/asxpdf/20200713/pdf/44kgkmcw8k51nn.pdf

This was published on 10th July - not positive but not warranted for this fall of 10% and no reaction was shown on 10th July.
Is there a surprise waiting ???
https://www.asx.com.au/asxpdf/20200710/pdf/44kdw17zxdjjsq.pdf
Searching for an answer - I found this is what Fools reported v
https://www.fool.com.au/2020/07/10/why-avita-chorus-evolution-new-hope-shares-are-dropping-lower/
https://www.fool.com.au/2020/07/10/avita-therapeutics-share-price-on-watch-after-q4-update/
Or could be the AVH stops trading in ASX ??
https://www.asx.com.au/asxpdf/20200629/pdf/44k1bw6w3ppsns.pdf

 

[Trav.]

@Miner who would have thought mate.

Some good figures there.....maybe people wanted more? I don't know the answer but some very strange moves all round on the market.

 

[peter2]

The main focus of hospitals in the US is COVID-19. All resources have been deployed to deal with this major public health issue at the expense of other important health issues. Hospital administrators won't have the time to look at other significant medical solutions until COVID-19 is well under control.

It's got to be tough for companies like AVH and PVN to get and hold administrator attention on their solutions for burn victims. If the medical treatments of AVH and PNV provide better medical outcomes and cost reductions then they will be in demand in the future.

Shareholders will have to be very patient during this pandemic.

 

[Miner]

The main focus of hospitals in the US is COVID-19. All resources have been deployed to deal with this major public health issue at the expense of other important health issues. Hospital administrators won't have the time to look at other significant medical solutions until COVID-19 is well under control.

It's got to be tough for companies like AVH and PVN to get and hold administrator attention on their solutions for burn victims. If the medical treatments of AVH and PNV provide better medical outcomes and cost reductions then they will be in demand in the future.

Shareholders will have to be very patient during this pandemic.

Thanks @peter2 and @Trav.
Good there is nothing alarming here.
I put a buy order at $7.5 and $7.1 thinking they will never happen and forgot to follow.
Today both got executed letting me think this could be a heart burn for me.

 

[Miner]

https://www.asx.com.au/asxpdf/20200716/pdf/44kkvq5k0fzfj0.pdf
Another announcement with Company pleased and market banged to move the share price further south. Where is @greggles to announce bottom is come

 

[Telamelo]

AVH good looking bullish chart in crossing above $7.50 on very good volume/momentum etc.

Please DYOR .. Cheers tela

 

[Miner]

https://www.asx.com.au/asxpdf/20200914/pdf/44mmczt97swp93.pdf - director selling and
https://www.asx.com.au/asxpdf/20200915/pdf/44mn21ltcjf4w0.pdf - director had enough and not going to recontest.
the volume of transaction did not show any spike either.
With US situation unless it is COVID 19 benefit, rest of medical stocks are not flying.
waiting with great patience.

 

[finicky]

Weird. I Looked at this one just today. Chart looks to have possibilities but I'd need a strong reason to buy anything these days and that is not provided by a company that is making rapid strides in revenue but the same in mounting losses. Seems a good speculation for a global market in various skin maladies,vitiligo is what got me looking at it, with a good pedigree in a sense coming out the burn research of that professor Fiona Whatsit but how long before it becomes a real business justifying the current price of 26x revenue? I'll look again in the crash.

 

[Dona Ferentes]

In July 2020, Avita switched its primary listing to the US Nasdaq index given 95 per cent of its revenue comes from the US with nearly all its employees there too.

Morningstar forecasts a loss of $US14 million on sales of $US42 million by financial 2022 and has a fair value estimate of $18 on its ASX-listed shares.

On Tuesday, the shares changed hands for $7.51 and are up more than six-fold in five years on the back of its US sales growth; the shares on Wall Street last traded at $US27.18 based on five ASX CDIs being worth one share in the Nasdaq listing.

 

[aus_trader]

Happy to monitor AVH as @finicky said.

But looks like a lot of Biotech experts here ?

I don't want to contaminate this thread by posting about another much smaller biotech, but could the experts please have a look at my question at the IMC thread ?

IMC - Immuron Limited

 

[peter2]

There's a real need for the AVH process for regenerating skin (and also PNV's process for burns) . We all neglect this most important organ, our own skin. Both processes have shown attractive economic benefits as well as the medical ones.

Unfortunately it takes time to get a new procedure into a medical setting (hospitals) and currently they're focused on one thing only (COVID-19). It's going to be a long wait before AVH and PNV can significantly increase their revenue.

 

[System]

On January 21st, 2021, AVITA Therapeutics, Inc changed its name to AVITA Medical, Inc.

 

[debtfree]

It's been a year since the last post so I thought I throw up a weekly chart of AVH.
I know there were 4 reports that came out yesterday (27th August), I haven't viewed them but just letting you know of them, I'll leave this area to the guys that are good with report reading.

Weekly Chart: AVH got punished in the market pullback Feb/Mar 20 (fell from $17+ down to $6.50) and has struggled since, falling to a low of $4.40 in June.

No previous high after a higher low has been taken out since which is the situation at the moment. Volatility has decreased as you can see the Bollinger Bands are coming closer together - $4.50 support looks good - a higher low - ready to break the down trendline - some buying in Jan, June and now by the looks of things, moving averages are close together.

Is this going to be the start of the trend upward ? Only time will tell but first, lets see if it can break that previous high of $5.89 and drag the short MA above the Long MA.

 

[finicky]

How it's going. Chart has further deteriorated. Nothing to buy here yet imo, if ever. Although Montgomery Investments disagrees - posted a substantial holder notice back in Nov 1 2021.
Quite a few announcements about equity payments to management.
Half ending Dec 31 - more revenue offset by higher operating costs.
If the business ever floats without burning capital then management will come out ok.

Weekly

 

[Country Lad]

Nothing to buy here yet imo, if ever. Although Montgomery Investments disagrees - posted a substantial holder notice back in Nov 1 2021.

Interesting @finicky, I'm with you. There is not much Montgomery says that fills me with confidence. So far he is down the chute by $1.485 million on his holdings in AVH.

 

[debtfree]

Time for a chart update. Well this has been a big tumble from the top, finally looks like the bottom might be in. Time will only tell, as always.

 

[finicky]

Damn, I think I talked myself out of this. Stopped checking on it. This chart has developed well, kudos to debtfree.

WEEKLY